An Unusual Presentation of an Uncommon Drug: A Case Report on Phenibut Overdose.

Cureus

Emergency Medicine, Henry Ford Health System, Wyandotte, USA.

Published: April 2022

Phenibut (β-phenyl-γ-aminobutyric acid), a nootropic, gamma-aminobutyric acid receptor agonist, commercially marketed for anxiolysis, is increasingly recognized for its recreational abuse potential. We present the case of a 30-year-old-male with a history of polysubstance abuse, anxiety, and depression, who presented to the Emergency Department by ambulance for altered mental status with severe agitation, requiring both sedation and mechanical ventilation. It was later discovered that he had consumed phenibut, which he purchased through the internet. Currently, no readily available confirmatory laboratory tests exist to aid in the diagnosis of acute phenibut intoxication. We highlight the clinical distinctions between features of acute phenibut intoxication and withdrawal.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078085PMC
http://dx.doi.org/10.7759/cureus.23913DOI Listing

Publication Analysis

Top Keywords

acute phenibut
8
phenibut intoxication
8
phenibut
5
unusual presentation
4
presentation uncommon
4
uncommon drug
4
drug case
4
case report
4
report phenibut
4
phenibut overdose
4

Similar Publications

At the present stage, great progress has been achieved in understanding the mechanisms of the development of cerebral ischemia. This became possible due to the achievements of theoretical disciplines, in connection with which the general biological approach was formed in the study of pathogenesis of acute and chronic cerebrovascular disorders (CVD). The discovery of pathways of free radical oxidation in cerebral ischemia made it possible to substantiate and develop therapeutic strategies using drugs with antioxidant and neuroprotective activity.

View Article and Find Full Text PDF

: Phenibut is a central nervous system drug that is registered and used in clinical practice as a prescription medication. In recent decades, the drug has become popular as a "nootropic and cognition enhancer" because of its active marketing as a dietary or food supplement sold online. This has resulted in a growing number of case reports on acute toxicity and withdrawal symptoms and has raised concerns about the quality of phenibut-containing products.

View Article and Find Full Text PDF

Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal.

J Clin Pharmacol

June 2024

Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.

β-Phenyl-γ-aminobutyric acid (phenibut) is an analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that was first synthesized in Russia in the early 1960s. It is marketed as a nootropic (smart drug) to improve cognitive performance, and to treat generalized and social anxiety, insomnia, and alcohol withdrawal. The use of phenibut is legal in the USA and it is widely available online without a prescription.

View Article and Find Full Text PDF

An Unusual Presentation of an Uncommon Drug: A Case Report on Phenibut Overdose.

Cureus

April 2022

Emergency Medicine, Henry Ford Health System, Wyandotte, USA.

Phenibut (β-phenyl-γ-aminobutyric acid), a nootropic, gamma-aminobutyric acid receptor agonist, commercially marketed for anxiolysis, is increasingly recognized for its recreational abuse potential. We present the case of a 30-year-old-male with a history of polysubstance abuse, anxiety, and depression, who presented to the Emergency Department by ambulance for altered mental status with severe agitation, requiring both sedation and mechanical ventilation. It was later discovered that he had consumed phenibut, which he purchased through the internet.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!